Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

Nature Immunology 18, 1004 (2017).
doi:10.1038/ni.3800

Authors: Yulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, Susanna S Ng, Arabella Young, Shin Foong Ngiow, Jai Rautela, Jasmin Straube, Nic Waddell, Stephen J Blake, Juming Yan, Laurent Bartholin, Jason S Lee, Eric Vivier, Kazuyoshi Takeda, Meriem Messaoudene, Laurence Zitvogel, Michele W L Teng, Gabrielle T Belz, Christian R Engwerda, Nicholas D Huntington, Kyohei Nakamura, Michael Hölzel & Mark J Smyth

Source: Nature Immunology - July 31, 2017 Category: Allergy & Immunology Authors: Yulong Gao Fernando Souza-Fonseca-Guimaraes Tobias Bald Susanna S Ng Arabella Young Shin Foong Ngiow Jai Rautela Jasmin Straube Nic Waddell Stephen J Blake Juming Yan Laurent Bartholin Jason S Lee Eric Vivier Kazuyoshi Takeda Meriem Messaoudene Laurence Z Tags: Article Source Type: research